The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils

NCT00673218 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Allergy

Interventions

DRUG: Placebo
DRUG: Xolair

Sponsor

Creighton University

Collaborators

[object Object]